Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1984-02-15
1986-03-25
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
424 22, 514965, 514953, C07C 3702
Patent
active
045783845
ABSTRACT:
A novel material consisting of a combination of a proteolipid and biodegradable, biocompatible copolymer has been developed for improving and accelerating the healing of osseous tissue. The proteolipid was prepared by combining muco-peptide-N-acetyl-muramoylhydrolase with phosphatidyl inositol, 4,5-diphosphate and the copolymer consists essentially of a 50:50 poly(L)(-)lactide co-glycolide.
REFERENCES:
patent: 3773919 (1973-11-01), Baswell et al.
patent: 3887699 (1975-06-01), Yolles
patent: 3976071 (1976-08-01), Sadek
Hollinger, Jeffrey O., Biomat., Med. Dev., Art. Org., 10(2), pp. 71-83 (1).
Hollinger, Jeffrey O., Journal of Biomedical Materials Research, vol. 17, pp. 71-82 (1983).
Bellamy Werten F. W.
Moezie F. T.
Phillips Delbert R.
Raubitschek John H.
Spechler Arthur I.
LandOfFree
Polylactic-polyglycolic acids combined with an acidic phospholip does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polylactic-polyglycolic acids combined with an acidic phospholip, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polylactic-polyglycolic acids combined with an acidic phospholip will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-630994